Market Place
Sourcing Support
Cash-strapped eye disease biotech halves portfolio
08 Aug 2023 //
FIERCE BIOTECH
Groundbreaking trial underway to improve vision in individuals with RP
14 Feb 2023 //
PR NEWSWIRE
Kiora Pharmaceuticals concludes subject enrolment in PCED therapy trial
05 Jan 2023 //
CLINICAL TRIALS ARENA
Kiora Pharmaceuticals Announces Publication of Pha1 Trial Results for KIO-100
17 Oct 2022 //
PRESS RELEASE
Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
13 Oct 2022 //
PRESS RELEASE
Kiora gets approval to begin Phase Ib retinitis pigmentosa trial
30 Jun 2022 //
CLINICALTRIALSARENA
EyeGate Pharma Completes Enrollment in PII Proof-of-Concept Study for PP-001
08 Sep 2021 //
GLOBENEWSWIRE
EyeGate Appointment of Brian M. Strem, Ph.D., as President and CEO
26 Jul 2021 //
GLOBENEWSWIRE
EyeGate Pharma Announces 1st Patient Dosed for PP-001 in a Phase 2 study
14 Jun 2021 //
OPHTHALMOLOGY TIMES
EyeGate Reports Q1 2021 Financial Results and Provides Business Update
12 May 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.